Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("CLOBETASOL PROPIONATE")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 242

  • Page / 10

Export

Selection :

  • and

Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasisMRAZ, Serena; LEONARDI, Craig; COLON, Luz E et al.Journal of dermatological treatment. 2008, Vol 19, Num 6, pp 354-359, issn 0954-6634, 6 p.Article

Topical Monotherapy With Clobetasol Propionate Spray 0.05% in the COBRA TrialMENTER, Alan.Cutis (New York, NY). 2007, Vol 80, Num 5, pp 12-19, issn 0011-4162, 8 p., SUPArticle

OBSERVATIONS ON THE SYSTEMIC EFFECT OF TOPICAL CLOBETASOL PROPIONATE (DERMOVATE). = OBSERVATIONS SUR L'EFFET SYSTEMIQUE DU CLOBETASOL PROPIONATE EN APPLICATION LOCALECARRUTHERS JA; AUGUST PJ; STAUGHTON RCD et al.1975; BRIT. MED. J.; G.B.; DA. 1975; NO 5990; PP. 203-204; BIBL. 9 REF.Article

Effectiveness of Clobetasol Propionate Spray 0.05% Added to Other Stable Treatments : Add-on Therapy in the COBRA TrialFELDMAN, Steven R.Cutis (New York, NY). 2007, Vol 80, Num 5, pp 20-28, issn 0011-4162, 9 p., SUPArticle

Clobetasol Propionate Spray 0.05% for the Treatment of Moderate to Severe Plaque PsoriasisMENTER, Alan.Cutis (New York, NY). 2012, Vol 89, Num 2, pp 89-94, issn 0011-4162, 6 p.Article

CLOBETASOL PROPIONATE OINTMENT COMPARED WITH DITHRANOL IN LASSAR'S PATE IN THE TREATMENT OF PSORIASISMARRIOTT PJ; MUNRO DD.1976; BRIT. J. DERMATOL.; G.B.; DA. 1976; VOL. 94; NO 12; PP. 101-106; BIBL. 14 REF.Article

EFFECTS ON ADRENAL FUNCTION OF TOPICALLY APPLIED CLOBETASOL PROPIONATE (DERMOVATE) = EFFET SUR LA FONCTION SURRENALIENNE DU PROPIONATE DE CLOBETASOL (DERMOVATE) APPLIQUE LOCALEMENTALLENBY CF; MAIN RA; MARSDEN RA et al.1975; BRIT. MED. J.; G.B.; DA. 1975; NO 5997; PP. 619-621; BIBL. 17 REF.Article

Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasisMAZZOTTA, Annamaria; ESPOSITO, Maria; CARBONI, Isabella et al.Journal of dermatological treatment. 2007, Vol 18, Num 2, pp 84-87, issn 0954-6634, 4 p.Article

Bioavailability of clobetasol propionate in different vehiclesFRANZ, T. J; LEHMAN, P. A; FELDMAN, S. R et al.Skin pharmacology and applied skin physiology. 2003, Vol 16, Num 4, pp 212-216, issn 1422-2868, 5 p.Article

Pharmacokinetics study about topical clobetasol on oral mucosaVARONI, Elena M; MOLTENI, Alessia; SARDELLA, Andrea et al.Journal of oral pathology & medicine. 2012, Vol 41, Num 3, pp 255-260, issn 0904-2512, 6 p.Article

Cushing syndrome caused by topical corticosteroid : A case reportGEN, Ramazan; AKBAY, Esen; SEZER, Kerem et al.The American journal of the medical sciences. 2007, Vol 333, Num 3, pp 173-174, issn 0002-9629, 2 p.Article

Clobetasol Propionate Shampoo 0.05% Is Efficacious and Safe for Long-term Control of Scalp PsoriasisPOULIN, Yves; PAPP, Kim; BISSONNETTE, Robert et al.Cutis (New York, NY). 2010, Vol 85, Num 1, pp 43-50, issn 0011-4162, 8 p.Article

Trichostasis spinulosa : possible association with prolonged topical application of clobetasol propionate 0.05% creamJANJUA, Shahbaz A; MCKOY, Karen C; IFTIKHAR, Nadia et al.International journal of dermatology. 2007, Vol 46, Num 9, pp 982-985, issn 0011-9059, 4 p.Article

Short-Contact Clobetasol Propionate Shampoo 0.05% Improves Quality of Life in Patients With Scalp PsoriasisTAN, Jerry; THOMAS, Richard; WANG, Béatrice et al.Cutis (New York, NY). 2009, Vol 83, Num 3, pp 157-164, issn 0011-4162, 8 p.Article

Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom traysGONZALEZ-MOLES, Miguel Angel; RUIZ-AVILA, Isabel; RODRIGUEZ-ARCHILLA, Alberto et al.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2003, Vol 95, Num 6, pp 688-692, issn 1079-2104, 5 p.Article

Clobetasol propionate emollient 0.05 percent : Hypothalamic-pituitary-adrenal-axis safety and four-week clinical efficacy results in plaque-type psoriasisJORIZZO, J. L; MAGEE, K; STEWART, D. M et al.Cutis (New York, NY). 1997, Vol 60, Num 1, pp 55-60, issn 0011-4162Article

Clobetasol Propionate Spray 0.05% Add-on Therapy to a Stable Regimen of Biologic Treatment in Patients With Moderate to Very Severe Plaque PsoriasisFELDMAN, Steven R; KOO, John Y. M; JOHNSON, Lori A et al.Cutis (New York, NY). 2009, Vol 84, Num 4S, pp 25-32, issn 0011-4162, 8 p., SUPArticle

VERGLEICHENDE STUDIEN ZWISCHEN CLOBETASOL-17-PROPIONAT UND ANDEREN GEBRAEUCHLICHEN KORTIKOID-EXTERNA IM DOPPELBLINDVERSUCH = ETUDES COMPARATIVES ENTRE LE 17-PROPIONATE DE CLOBETASOL ET LES AUTRES POMMADES CORTICOIDES USUELLES DANS UNE EXPERIENCE EN DOUBLE AVEUGLEBECK M; BERGER C; FILIPP N et al.1981; H+G, Z. HAUTKR.; ISSN 0301-0481; DEU; DA. 1981; VOL. 56; NO 16; PP. 1066-1070; 5 P.; ABS. ENG; BIBL. 3 REF.Article

IL CLOBETASOLO 17-PROPIONATO NEL TRATTAMENTO DELLA PSORIASI E DELLE DERMATITI ECZEMATOSE: VALUTAZIONE CLINICA DELL' ATTIVITA TERAPEUTICA = LE PROPIONATE 17 DE CLOBETASOL DANS LE TRAITEMENT DU PSORIASIS ET DES DERMATOSES ECZEMATEUSES. EVALUATION CLINIQUE DE L'ACTIVITE THERAPEUTIQUEGOITRE M; FORTE M; SARTORIS S et al.1979; G. ITAL. DERMATOL., MINERVA DERMATOL.; ITA; DA. 1979; VOL. 114; NO 11; PP. 631-636; ABS. ENG; BIBL. 27 REF.Article

INTERMITTENT TREATMENT OF PSORIASIS WITH CLOBETASOL PROPIONATEHRADIL E; LINDSTROM C; MOLLER H et al.1978; ACTA DERMATO-VENEREOL.; SWE; DA. 1978; VOL. 58; NO 4; PP. 375-377; BIBL. 5 REF.Article

TOPICAL CLOBETASOL PROPIONATE IN THE TREATMENT OF SCALP PSORIASIS: A MEDIUM TERM FOLLOW-UPZAR E.1980; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1980; VOL. 28; NO 6; PART. 2; PP. 997-1001; BIBL. 12 REF.Article

A PROPOS D'UN NOUVEAU CORTICOIDE A USAGE LOCAL: NOUVEAU. VRAIMENT.RUDLOFF J.1980; OUEST MED.; FRA; DA. 1980; VOL. 33; NO 8; PP. 407-408Article

COMPARISON OF CLOBETASOL PROPIONATE AND BETAMETHASONE-17,21-DIPROPIONATE WITH REFERENCE TO ADRENAL SUPPRESSIONERIKSEN K.1979; ACTA DERMATO-VENEREOL.; SWE; DA. 1979; VOL. 59; NO 4; PP. 372-374; BIBL. 13 REF.Article

EFFECTS OF GLUCOCORTICOSTEROIDS ON CULTURED HUMAN SKIN FIBROBLASTS. V: INFLUENCE OF ANABOLIC STEROIDS ON THE INHIBITORY EFFECTS OF CLOBETASOL-17-PROPIONATE ON CELL PROLIFERATION AND COLLAGEN SYNTHESISPONEC M; DE HAAS C; KEMPENAAR JA et al.1979; ARCH. DERMATOL. RES.; DEU; DA. 1979; VOL. 266; NO 1; PP. 75-82; ABS. GER; BIBL. 12 REF.Article

MANAGING CHRONIC SKIN CONDITIONS WITH TWO DIFFERING TOPICAL CORTICOSTEROIDSWOODBRIDGE PA; SPARKES CG.1979; DERMATOLOGICA; CHE; DA. 1979; VOL. 158; NO 4; PP. 299-306; BIBL. 20 REF.Article

  • Page / 10